Clinical Trials Browser

NIH × Fallopian Tube Neoplasms × Sorafenib × Clear all

NCT00436215 2020-11-23

Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer

Phase 2 Completed

55 enrolled 12 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms